Delivery device as a booster for Cell & Gene Therapy success
Cell and gene therapy delivery is an emergent and transformative industry.
Cell and gene therapy delivery is an emergent and transformative industry.
EVEON and Sensorion collaborating to develop an injection system for the delivery of gene therapy treatments into the inner ear
EVEON exhibited at Pharmapack - booth F68 and at Innovation Gallery, on February 1-2, 2023 in Paris (France).
Read the latest article published in OnDrugDelivery about the current challenges faced by the topical spray-based delivery of therapeutics. And how our Ad-Mist™ spray nozzle overcomes these challenges to harness the potential of this delivery route.
During the last years, drug delivery has evolved and new routes of administration have emerged.
JBT HubUp alliance has celebrated its 5th anniversary and exhibited at the international CPHI exhibition in Frankfurt (Germany), 1-3 November 2022.
EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates.
EVEON is exploring the Asian medical device market, including South Korea and Japan, as part of the French Healthcare Booster.
Our medical device Intuity® Spray received an award at the Pharmapack 2021 exhibition in the exhibitor - administration mode category.
EVEON has developed Ad-Mist™, an airless spray nozzle that can be used to produce fine droplets in the form of a mist.